Medinotec (MDNC) Operating Leases (2024 - 2025)

Medinotec (MDNC) reported Operating Leases of $5355.0 for Q2 2025, down 84.19% on a YoY basis from $33873.0 in Q2 2024, and down 57.82% quarter-over-quarter from $12696.0 in Q1 2025.

Medinotec (MDNC) Operating Leases (2024 - 2025) Analysis & Trends

Medinotec has reported Operating Leases for 2 years, with the latest figure at $5355.0 in Q2 2025.

  • For the quarter ending Q2 2025, Operating Leases fell 84.19% year-over-year to $5355.0; the trailing twelve-month figure through May 2025 stood at $5355.0 (down 84.19% YoY), and the FY2025 full-year result was $12696.0, down 68.02% from the prior year.
  • Operating Leases for Q2 2025 stood at $5355.0, down from $12696.0 in the prior quarter.
  • The five-year high for Operating Leases was $39698.0 in Q1 2024, with the low at $5355.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 157.80 Bn 151.14 Bn 6.27 Bn
2 Stryker 115.54 Bn 112.66 Bn 3.81 Bn
3 Medtronic 103.44 Bn 95.27 Bn 5.76 Bn
4 Boston Scientific 72.38 Bn 71.17 Bn 3.61 Bn
5 Edwards Lifesciences 49.76 Bn 46.09 Bn 1.29 Bn
6 Dexcom 29.53 Bn 28.42 Bn 750.30 Mn
7 GE HealthCare Technologies 29.51 Bn 27.44 Bn 1.98 Bn
8 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
9 Steris 20.69 Bn 20.27 Bn 697.10 Mn
10 Medinotec - - 854,557.00

Historic Data

Download Data
DateValue
May 31, 2025 5,355.00
Feb 28, 2025 12,696.00
Nov 30, 2024 20,731.00
Aug 31, 2024 28,454.00
May 31, 2024 33,873.00
Feb 29, 2024 39,698.00